《柳叶刀神经杂志2025》修正；24: 65 - 76

The Lancet Neurology Pub Date : 2024-12-20 DOI:10.1016/s1474-4422(24)00516-7

{"title":"《柳叶刀神经杂志2025》修正；24: 65 - 76","authors":"","doi":"10.1016/s1474-4422(24)00516-7","DOIUrl":null,"url":null,"abstract":"Gettings JV, Mohammad Alizadeh Chafjiri F, Patel AA, et al. Diagnosis and management of status epilepticus: improving the status quo. The Lancet Neurology 2025; 24: 65–76—In figure 2 of this Review, the first-line intranasal diazepam dose should have read “5–20 mg”. This correction has been made to the online version as of Dec 20, 2024.","PeriodicalId":22676,"journal":{"name":"The Lancet Neurology","volume":"265 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Lancet Neurol 2025; 24: 65–76\",\"authors\":\"\",\"doi\":\"10.1016/s1474-4422(24)00516-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gettings JV, Mohammad Alizadeh Chafjiri F, Patel AA, et al. Diagnosis and management of status epilepticus: improving the status quo. The Lancet Neurology 2025; 24: 65–76—In figure 2 of this Review, the first-line intranasal diazepam dose should have read “5–20 mg”. This correction has been made to the online version as of Dec 20, 2024.\",\"PeriodicalId\":22676,\"journal\":{\"name\":\"The Lancet Neurology\",\"volume\":\"265 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s1474-4422(24)00516-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s1474-4422(24)00516-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

Gettings JV, Mohammad Alizadeh Chafjiri F， Patel AA等。癫痫持续状态的诊断和治疗：改善现状。《柳叶刀神经病学2025》；[24:65 - 76]在本综述的图2中，一线鼻内地西泮剂量应为“5 - 20mg”。此更正已于2024年12月20日对在线版本进行了修改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to Lancet Neurol 2025; 24: 65–76

Gettings JV, Mohammad Alizadeh Chafjiri F, Patel AA, et al. Diagnosis and management of status epilepticus: improving the status quo. The Lancet Neurology 2025; 24: 65–76—In figure 2 of this Review, the first-line intranasal diazepam dose should have read “5–20 mg”. This correction has been made to the online version as of Dec 20, 2024.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Lancet Neurology

自引率

0.00%

发文量